Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 24, 2018 06:55 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics Announces Reimbursement Expansion of ThyGeNEXT™

State of Pennsylvania and New York Approve Commercialization of New Thyroid Cancer Test PARSIPPANY, NJ, Sept. 24, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (IDXG), announced...
September 17, 2018 08:30 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics Supports Research Efforts of Pancreatic and Thyroid Cancer Patient Advocacy Groups

Interpace Employees Participate in Local Events in Support of Lustgarten Foundation for Pancreatic Cancer Research, Thyroid, Head and Neck Cancer Foundation, and Pancreatic Cancer Action Network ...
August 27, 2018 08:30 ET | Source: Interpace Diagnostics Group, Inc.

INTERPACE DIAGNOSTICS ANNOUNCES PARTICIPATION AT THE 20TH ANNUAL GLOBAL INVESTMENT CONFERENCE SPONSORED BY H.C.WAINWRIGHT & CO.

PARSIPPANY, NJ, Aug. 27, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) (“Interpace” or “the Company”), a fully integrated commercial and bioinformatics company that...
August 20, 2018 16:30 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics to Present at the 10th Annual Next Generation Dx Summit 2018

Discussing Methods for Securing Coverage and Reimbursement for Molecular Diagnostics PARSIPPANY, NJ, Aug. 20, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG)...
August 15, 2018 08:30 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics Acquires Select Assets of Rosetta Genomics Out of Bankruptcy

Several Former Rosetta Employees and Select Customers Also Join Interpace Parsippany, NJ, Aug. 15, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) (“Interpace” or “the...
August 09, 2018 16:46 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics Group Reports Second Quarter 2018 Financial Results, Business Progress and Recent Accomplishments

Revenue Grew 43% Over the Prior Year’s Quarter and 14% Over the Prior Period Record Quarterly Revenue of $5.5 Million Cash & Cash Equivalents of $10.1 Million with No Long-Term Debt Now Covered...
August 01, 2018 08:30 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics to Host Conference Call and Webcast to Discuss Second Quarter 2018 Financial Results on Thursday, August 9, 2018

PARSIPPANY, NJ, Aug. 01, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc., (“Interpace” or “the Company”) announced today that it will report its second quarter 2018 financial results...
July 31, 2018 08:30 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics Regains Compliance with NASDAQ Minimum Bid Price Listing Requirement

PARSIPPANY, NJ, July 31, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) (“Interpace” or “the Company”), a fully integrated commercial and bioinformatics company that...